Pharmacists Weigh In on Patients Turning to AI for Medication Advice

Patients are increasingly consulting artificial intelligence chatbots about their medications, and a new qualitative study offers a look at how pharmacists on the front lines view this shift. Researchers conducted semi-structured face-to-face interviews with ten pharmacists at Zhongshan Hospital of Xiamen University in Fujian Province, China, using purposive sampling to include pharmacists with diverse professional backgrounds and experience. The study, published in BMC Health Services Research, analyzed verbatim transcripts with thematic analysis in NVivo 15 and distilled the pharmacists’ views into seven core themes.

The overall picture was one of cautious acceptance. The pharmacists generally favored patients using AI to obtain medication information, recognizing its merits and describing its value as an auxiliary tool for health education and for improving the efficiency of pharmaceutical services. At the same time, they flagged clear boundaries: the participants highlighted AI’s limitations in complex clinical scenarios and raised concerns about the reliability of the information these platforms provide. In other words, the pharmacists saw AI as useful for routine questions and background knowledge, but not as a substitute for professional judgment when cases become complicated.

Notably, the pharmacists did not view patients as a uniform group. The study found that patient-related factors also shaped how AI consultation played out in practice, suggesting that who the patient is and how they use these tools affects whether AI-mediated advice is helpful or problematic. This nuance matters for anyone hoping to integrate AI into pharmacy services, because the same technology may serve different patients very differently.

Where the pharmacists drew their sharpest distinctions was in what they considered irreplaceable about their own profession. They emphasized their advantages in personalized guidance, humanistic care, and risk identification — functions that current AI platforms cannot fully replicate. A pharmacist can adjust advice to a patient’s specific regimen, spot dangerous red flags, and provide the reassurance that comes from a human encounter. The participants also looked ahead to how widespread AI adoption might reshape their profession itself: they noted that AI popularization may change consultation volumes, alter communication dynamics between pharmacists and patients, and shift the professional competencies pharmacists will need in the future.

Beyond describing the current landscape, the pharmacists proposed targeted recommendations for how patients should use AI tools. The findings, according to the research team, provide a basis for policy formulation, for AI application training, and for optimizing AI systems themselves, with the goal of promoting rational integration of these technologies and safeguarding medication safety. The study’s design is important to keep in mind when interpreting its conclusions. It captured the views of just ten pharmacists at a single tertiary hospital, and qualitative interviews of this kind are well suited to surfacing themes, concerns, and reasoning in depth, but they do not measure how often patients actually use AI for medication questions or whether such use leads to better or worse outcomes. The seven themes identified here represent the perspectives of this particular group of pharmacists rather than a statistical portrait of the profession. Even so, the study arrives at a moment when the integration of AI into healthcare is accelerating globally. The pharmacists’ message, as the authors summarize it, is that AI holds genuine auxiliary potential for medication consultation, but its role is best understood as complementary — with pharmacists retaining an irreplaceable role in personalized care, safety checking, and the human dimension of medication use.

Subject of Research: Pharmacists’ perspectives on patient use of artificial intelligence-mediated medication consultation: a qualitative study at a tertiary hospital in Fujian Province of China

Article Title: Pharmacists’ perspectives on patient use of artificial intelligence-mediated medication consultation: a qualitative study at a tertiary hospital in Fujian Province of China

Article References: Huang, X., Yu, L., Wu, J., Lin, X., Wang, X., & Yu, X. (2026). Pharmacists’ perspectives on patient use of artificial intelligence-mediated medication consultation: a qualitative study at a tertiary hospital in Fujian Province of China. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15924-x

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15924-x

Keywords: artificial intelligence, pharmacists, medication consultation, qualitative study, pharmaceutical services, medication safety, health education, tertiary hospital, thematic analysis, China, perspectives, patient